Atom Investors’s Avanos Medical AVNS Stock Holding History

Atom Investors’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-8,750	Closed	-$210K	–	500
2024 Q3	$210K	Buy	+8,750	New	+$200K	0.02%	413

Other funds holding AVNS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

WHG

Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return

Atom Investors's AVNS Position: Q4 2024 in Review

Atom Investors sold out of Avanos Medical (AVNS) in Q4 2024, closing a stake of 8,750 shares — an estimated $210K sold.

Atom Investors first reported a position in AVNS in Q3 2024 and held it in 1 quarter. The position peaked at $210K in Q3 2024. 258 funds tracked by Wall St. Rank hold AVNS as of Q4 2024.

Atom Investors reported no remaining Avanos Medical position as of Q4 2024 after selling out during the quarter.
Atom Investors sold 8,750 Avanos Medical shares in Q4 2024, an estimated $210K.
Atom Investors first reported a position in Avanos Medical in Q3 2024 and held it in 1 quarter.
Atom Investors's Avanos Medical position peaked at $210K in Q3 2024.
258 funds tracked by Wall St. Rank held Avanos Medical as of Q4 2024.

Based on Atom Investors's 13F filing for Q4 2024, filed 14 Feb 2025.